These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2965230

  • 1. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
    Bolli P, Müller FB, Linder L, Raine AE, Resink TJ, Erne P, Kiowski W, Bühler FR.
    J Hypertens Suppl; 1987 Dec; 5(5):S55-8. PubMed ID: 2965230
    [Abstract] [Full Text] [Related]

  • 2. The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
    Bolli P, Müller FB, Linder L, Raine AE, Resink TJ, Erne P, Kiowski W, Bühler FR.
    J Cardiovasc Pharmacol; 1989 Dec; 13 Suppl 6():S75-9. PubMed ID: 2473356
    [Abstract] [Full Text] [Related]

  • 3. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
    Schmitt M, Broadley AJ, Nightingale AK, Payne N, Gunaruwan P, Taylor J, Lee L, Cockcroft J, Struthers AD, Frenneaux MP.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1833-8. PubMed ID: 12842844
    [Abstract] [Full Text] [Related]

  • 4. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T, Ito Y, Noda H, Sato Y, Ando K, Kangawa K, Matsuo H.
    J Clin Invest; 1987 Sep 01; 80(3):832-40. PubMed ID: 3040808
    [Abstract] [Full Text] [Related]

  • 5. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
    Müller FB, Erne P, Raine AE, Bolli P, Linder L, Resink TJ, Cottier C, Bühler FR.
    J Hypertens Suppl; 1986 Jun 01; 4(2):S109-14. PubMed ID: 2941531
    [Abstract] [Full Text] [Related]

  • 6. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension].
    Musca A, Ferri C, Cammerella I, Onofri R, Tani S, Santucci A.
    Medicina (Firenze); 1989 Jun 01; 9(2):167-72. PubMed ID: 2530412
    [Abstract] [Full Text] [Related]

  • 7. Exaggerated atrial natriuretic peptide release during acute exercise in essential hypertension.
    Sudhir K, Woods RL, Jennings GL, Nelson LA, Laufer E, Korner PI.
    J Hum Hypertens; 1988 Mar 01; 1(4):299-304. PubMed ID: 2975706
    [Abstract] [Full Text] [Related]

  • 8. [The correlation of atrial natriuretic peptide values with those of renin, angiotensin and aldosterone in hypertension patients below and above 50].
    González Carmona VM, García R, Camacho P, Jerjes Sánchez C, Arévila N, Hernández H, Nieto Castillo S.
    Arch Inst Cardiol Mex; 1993 Mar 01; 63(5):435-9. PubMed ID: 8291930
    [Abstract] [Full Text] [Related]

  • 9. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
    Hulthén UL, Bolli P, Kiowski W, Bühler FR.
    J Cardiovasc Pharmacol; 1984 Mar 01; 6 Suppl 1():S75-81. PubMed ID: 6204162
    [Abstract] [Full Text] [Related]

  • 10. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
    Cockcroft JR, Allen MJ, Benjamin N, Webb DJ.
    J Hum Hypertens; 1989 Feb 01; 3(1):49-52. PubMed ID: 2542549
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR, Neubauer S, Obitz G, Ertl G.
    J Mol Cell Cardiol; 1994 Apr 01; 26(4):527-37. PubMed ID: 8072008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of reactive hyperemia and nifedipine on forearm vascular resistance in essential hypertension: evidence for functional abnormality.
    Schulte KL, Braun J, Meyer-Sabellek W, Gotzen R, Distler A.
    J Cardiovasc Pharmacol; 1987 Apr 01; 10 Suppl 10():S134-5. PubMed ID: 2455114
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May 01; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 19. The haemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive people and patients with essential hypertension.
    Ishii M, Sugimoto T, Matsuoka H, Hirata Y, Ishimistu T, Fukui K, Sugimoto T, Kangawa K, Matsuo H.
    J Hypertens Suppl; 1986 Dec 01; 4(6):S542-5. PubMed ID: 2956389
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.